Family Firm Inc. Purchases Shares of 313 DaVita Inc. (NYSE:DVA)

Family Firm Inc. purchased a new stake in DaVita Inc. (NYSE:DVAFree Report) during the 2nd quarter, Holdings Channel.com reports. The institutional investor purchased 313 shares of the company’s stock, valued at approximately $43,000.

Other institutional investors also recently modified their holdings of the company. Private Advisory Group LLC purchased a new position in DaVita during the 2nd quarter worth approximately $823,000. Hennessy Advisors Inc. purchased a new position in DaVita during the 2nd quarter worth approximately $8,439,000. Atria Wealth Solutions Inc. grew its position in DaVita by 26.7% during the 2nd quarter. Atria Wealth Solutions Inc. now owns 6,068 shares of the company’s stock worth $841,000 after purchasing an additional 1,279 shares in the last quarter. First Horizon Advisors Inc. grew its position in DaVita by 56.3% during the 2nd quarter. First Horizon Advisors Inc. now owns 1,632 shares of the company’s stock worth $226,000 after purchasing an additional 588 shares in the last quarter. Finally, Nisa Investment Advisors LLC grew its holdings in shares of DaVita by 26.8% during the 2nd quarter. Nisa Investment Advisors LLC now owns 36,694 shares of the company’s stock valued at $5,085,000 after acquiring an additional 7,752 shares in the last quarter. Institutional investors own 90.12% of the company’s stock.

Insider Activity

In other news, COO Michael David Staffieri sold 9,539 shares of the stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $150.03, for a total transaction of $1,431,136.17. Following the sale, the chief operating officer now directly owns 241,945 shares of the company’s stock, valued at $36,299,008.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, insider Kathleen Alyce Waters sold 7,857 shares of the stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $146.21, for a total value of $1,148,771.97. Following the transaction, the insider now directly owns 83,011 shares in the company, valued at $12,137,038.31. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, COO Michael David Staffieri sold 9,539 shares of the stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $150.03, for a total transaction of $1,431,136.17. Following the completion of the transaction, the chief operating officer now owns 241,945 shares in the company, valued at $36,299,008.35. The disclosure for this sale can be found here. 2.00% of the stock is owned by insiders.

Analyst Ratings Changes

Several equities research analysts recently issued reports on DVA shares. UBS Group lifted their price objective on shares of DaVita from $169.00 to $175.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. Bank of America upped their target price on shares of DaVita from $139.00 to $145.00 and gave the company an “underperform” rating in a research note on Wednesday, August 7th. Truist Financial upped their target price on shares of DaVita from $150.00 to $165.00 and gave the company a “hold” rating in a research note on Tuesday. StockNews.com cut shares of DaVita from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 8th. Finally, TD Cowen upped their target price on shares of DaVita from $139.00 to $150.00 and gave the company a “hold” rating in a research note on Wednesday, July 24th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, DaVita currently has a consensus rating of “Hold” and a consensus target price of $157.00.

Read Our Latest Analysis on DaVita

DaVita Price Performance

DaVita stock traded up $1.64 during trading hours on Friday, hitting $153.99. 475,434 shares of the stock were exchanged, compared to its average volume of 830,277. The company has a debt-to-equity ratio of 9.94, a quick ratio of 1.12 and a current ratio of 1.16. The stock has a market capitalization of $13.50 billion, a P/E ratio of 17.50, a P/E/G ratio of 0.87 and a beta of 0.87. DaVita Inc. has a 12 month low of $71.51 and a 12 month high of $155.56. The business’s 50-day moving average is $141.30 and its two-hundred day moving average is $136.20.

DaVita (NYSE:DVAGet Free Report) last released its quarterly earnings results on Tuesday, August 6th. The company reported $2.59 EPS for the quarter, beating the consensus estimate of $2.47 by $0.12. DaVita had a net margin of 6.86% and a return on equity of 77.00%. The business had revenue of $3.19 billion for the quarter, compared to analysts’ expectations of $3.15 billion. During the same period in the prior year, the firm earned $2.08 earnings per share. DaVita’s revenue was up 6.2% compared to the same quarter last year. Equities research analysts expect that DaVita Inc. will post 9.9 EPS for the current fiscal year.

About DaVita

(Free Report)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

See Also

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVAFree Report).

Institutional Ownership by Quarter for DaVita (NYSE:DVA)

Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.